A critical role for the programmed death ligand 1 in fetomaternal tolerance

Journal of Experimental Medicine

Volumn 202, Issue 2, 2005, Pages 231-237

  Guleria, Indira ^a   Khosroshahi, Arezou ^a   Ansari, Mohammed Javeed ^a   Habicht, Antje ^a   Azuma, Miyuki ^c   Yagita, Hideo ^d   Noelle, Randolph J ^e   Coyle, Anthony ^f   Mellor, Andrew L ^g   Khoury, Samia J ^b   Sayegh, Mohamed H ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d JUNTENDO UNIVERSITY   (Japan)

^e DARTMOUTH COLLEGE   (United States)

^f MILLENNIUM PHARMACEUTICALS INC   (United States)

^g MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; AUTOANTIGEN; GAMMA INTERFERON; LIGAND; PROGRAMMED DEATH LIGAND 1; RAG1 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SPECIFICITY; APOPTOSIS; ARTICLE; B LYMPHOCYTE; BLOOD LEVEL; COMPARATIVE STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; FETUS; FETUS DEATH; HELPER CELL; HETEROZYGOTE; HOMOGENATE; IMMUNE RESPONSE; IN VIVO STUDY; LYMPHOCYTE; MALE; MOUSE; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SURVIVAL RATE; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD80; FEMALE; FETAL RESORPTION; HOMEODOMAIN PROTEINS; IMMUNE TOLERANCE; INTERFERON TYPE II; MATERNAL-FETAL EXCHANGE; MEMBRANE GLYCOPROTEINS; MICE; MICE, KNOCKOUT; PEPTIDES; PREGNANCY; TH1 CELLS;

EID: 22944436502     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20050019     Document Type: Article

References (36)

1. Fournel, S., M. Aguerre-Girr, X. Huc, F. Lenfant, A. Alam, A. Toubert, A. Bensussan, and P. Le Bouteiller. 2000. Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8. J. Immunol. 164:6100-6104.
2. Hunt, J.S., D. Vassmer, T.A. Ferguson, and L. Miller. 1997. Fas ligand is positioned in mouse uterus and placenta to prevent trafficking of activated leukocytes between the mother and the conceptus. J. Immunol. 158:4122-4128.
3. Phillips, T.A., J. Ni, G. Pan, S.M. Ruben, Y.F. Wei, J.L. Pace, and J.S. Hunt. 1999. TRAIL (Apo-2L) and TRAIL receptors in human placentas: implications for immune privilege. J. Immunol. 162:6053-6059.
4. Xu, C., D. Mao, V.M. Holers, B. Palanca, A.M. Cheng, and H. Molina. 2000. A critical role for murine complement regulator crry in fetomaternal tolerance. Science. 287:498-501.
5. Munn, D.H., M. Zhou, J.T. Attwood, I. Bondarev, S.J. Conway, B. Marshall, C. Brown, and A.L. Mellor. 1998. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science. 281:1191-1193.
6. Mellor, A.L., J. Sivakumar, P. Chandler, K. Smith, H. Molina, D. Mao, and D.H. Munn. 2001. Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nat. Immunol. 2:64-68.
7. Aluvihare, V.R., M. Kallikourdis, and A.G. Betz. 2004. Regulatory T cells mediate maternal tolerance to the fetus. Nat. Immunol. 5:266-271.
8. Rothstein, D.M., and M.H. Sayegh. 2003. T-cell costimulatory pathways in allograft rejection and tolerance. Immunol. Rev. 196:85-108.
9. Khoury, S.J., and M.H. Sayegh. 2004. The roles of the new negative T cell costimulatory pathways in regulating autoimmunity. Immunity. 20:529-538.
10. Dong, V.M., K.L. Womer, and M.H. Sayegh. 1999. Transplantation tolerance: the concept and its applicability. Pediatr. Transplant. 3:181-192.
11. Ozkaynak, E., L. Wang, A. Goodearl, K. McDonald, S. Qin, T. O'Keefe, T. Duong, T. Smith, J.C. Gutierrez-Ramos, J.B. Rottman, et al. 2002. Programmed death-1 targeting can promote allograft survival. J. Immunol. 169:6546-6553.
12. Gao, W., G. Demirci, T.B. Strom, and X.C. Li. 2003. Stimulating PD-1-negative signals concurrent with blocking CD154 co-stimulation induces long-term islet allograft survival. Transplantation. 76:994-999.
13. Sandner, S. M.R. Clarkson, A.D. Salama, A. Sanchez-Fueyo, C. Do-menig, A. Habicht, N. Najafian, H. Yagita, H. M. Azuma, L.A. Turka, M.H. Sayegh. 2005. Role of programmed death-1 pathway in regulation of alloimmune response in vivo. J. Immunol. 174:3408-3415.
14. Ito, T., T. Ueno, M.R. Clarkson, X. Yuan, M.M. Jurewicz,, H. Yagita, M. Azuma, A.H. Sharpe, H. Auchincloss Jr., M. Sayegh, and N. Najafian. 2005. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo. J. Immunol. 174:6648-6656.
15. Freeman, G., A. Long, Y. Iwai, K. Bourque, T. Chernova, H. Nishimura, L. Fitz, N. Malenkovich, T. Okazaki, M. Byrne, H. Horton, L. Fouser, L. Carter, V. Ling, M. Bowman, B. Carreno, M. Collins, C. Wood, and T. Honjo. 2000. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 192:1-9.
16. Latchman, Y., C. Wood, T. Chernova, D. Chaudhary, M. Borde, I. Chernova, Y. Iwai, A. Long, J. Brown, R. Nunes, et al. 2001. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat. Immunol. 2:261-268.
17. Petroff, M.G., L. Chen, T.A. Phillips, D. Azzola, P. Sedlmayr, and J.S. Hunt. 2003. B7 family molecules are favorably positioned at the human maternal-fetal interface. Biol. Reprod. 68:1496-1504.
18. Dong, H., G. Zhu, K. Tamada, and L. Chen. 1999. B7-H1, a third member of the B7 family, co-stimulates T cell proliferation and interleukin-10 secretion. Nat. Med. 5:1365-1369.
19. Tamura, H., H. Dong, G. Zhu, G.L. Sica, D.B. Flies, K. Tamada, and L. Chen. 2001. B7-H1 costimulation preferentially enhances CD28-independent T-helper cell function. Blood. 97:1809-1816.
20. Wang, S., J. Bajorath, D.B. Flies, H. Dong, T. Honjo, and L. Chen. 2003. Molecular modeling and functional mapping of B7-H1 and B7-DC uncouple costimulatory function from PD-1 interaction. J. Exp. Med. 197:1083-1091.
21. Subudhi, S.K., P. Zhou, L.M. Yerian, R.K. Chin, J.C. Lo, R.A. Anders, Y. Sun, L. Chen, Y. Wang, M.L. Alegre, and Y.X. Fu. 2004. Local expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection. J. Clin. Invest. 113:694-700.
22. Latchman, Y.E., S.C. Liang, Y. Wu, T. Chernova, R.A. Sobel, M. Klemm, V.K. Kuchroo, G.J. Freeman, and A.H. Sharpe. 2004. PDL1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells. Proc. Natl. Acad. Sci. USA. 101:10691-10696.
23. Grohmann, U., C. Orabona, F. Fallarino, C. Vacca, F. Calcinaro, A. Falorni, P. Candeloro, M.L. Belladonna, R. Bianchi, M.C. Fioretti, and P. Puccetti. 2002. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat. Immunol. 3:1097-1101.
24. Guleria, I., and J.W. Pollard. 2000. The trophoblast is a component of the innate immune system during pregnancy. Nat. Med. 6:589-593.
25. Marzi, M., A. Vigano, D. Trabattoni, M.L. Villa, A. Salvaggio, E. Clerici, and M. Clerici. 1996. Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clin. Exp. Immunol. 106:127-133.
26. Piccinni, M.P., L. Beloni, C. Livi, E. Maggi, G. Scarselli, and S. Romagnani. 1998. Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions. Nat. Med. 4:1020-1024.
27. Salama, A.D., T. Chitnis, J. Imitola, M.J. Ansari, H. Akiba, F. Tushima, M. Azuma, H. Yagita, M.H. Sayegh, and S.J. Khoury. 2003. Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis. J. Exp. Med. 198:71-78.
28. Carter, L., L.A. Fouser, J. Jussif, L. Fitz, B. Deng, C.R. Wood, M. Collins, T. Honjo, G.J. Freeman, and B.M. Carreno. 2002. PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2. Eur. J. Immunol. 32:634-643.
29. Dong, H., S.E. Strome, D.R. Salomao, H. Tamura, F. Hirano, D.B. Flies, P.C. Roche, J. Lu, G. Zhu, K. Tamada, et al. 2002. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat. Med. 8:793-800.
30. Ishida, Y., Y. Agata, K. Shibahara, and T. Honjo. 1992. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J. 11:3887-3895.
31. Baecher-Allan, C., J.A. Brown, G.J. Freeman, and D.A. Hafler. 2001. Cd4(+)cd25(high) regulatory cells in human peripheral blood. J. Immunol. 167:1245-1253.
32. Yamazaki, T., H. Akiba, H. Iwai, H. Matsuda, M. Aoki, Y. Tanno, T. Shin, H. Tsuchiya, D.M. Pardoll, K. Okumura, et al. 2002. Expression of programmed death 1 ligands by murine T cells and APC. J. Immunol. 169:5538-5545.
33. Lenschow, D.J., S.C. Ho, H. Sattar, L. Rhee, G. Gray, N. Nabavi, K.C. Herold, and J.A. Bluestone. 1995. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J. Exp. Med. 181:1145-1155.
34. Baban, B., P. Chandler, D. McCool, B. Marshall, D.H. Munn, and A.L. Mellor. 2004. Indoleamine 2,3-dioxygenase expression is restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specific. J. Reprod. Immunol. 61:67-77.
35. Ansari, M.J., A.D. Salama, T. Chitnis, R.N. Smith, H. Yagita, H. Akiba, T. Yamazaki, M. Azuma, H. Iwai, S. Khoury, H. Auchincloss Jr., M.H. Sayegh. 2003. The programmed death-1 pathway regulates autoimmune diabetes in NOD mice. J. Exp. Med. 198:63-69.
36. Harada, H., A.D. Salama, M. Sho, A. Izawa, S.E. Sandner, T. Ito, H. Akiba, H. Yagita, A.H. Sharpe, G.J. Freeman, and M.H. Sayegh. 2003. The role of the ICOS-B7h T cell costimulatory pathway in transplantation immunity. J. Clin. Invest. 112:234-243.